(1)
Tomei, L. Efficacy and Safety of Oral Immunotherapy in Children Aged 1-3 Years With Peanut Allergy (the Immune Tolerance Network IMPACT trial): A Randomised Placebo-Controlled Study. IJPAI 2023, 36, 40-41.